Clinical research sites win study awards in one of three ways:
- They run their own outbound system
- They hire a business development agency or manager
- They join a network that pitches them to sponsors
This page compares the realistic options in all three groups, with honest notes on cost and fit. The first entry is our own product, listed with that disclosure up front.
| Option | Price | Best for | Weakness |
|---|---|---|---|
| Lead Gen Library system (ours) | Roughly $180 a month | Sites that want to own their study flow | You have to operate the software |
| Business development agency | $3,000 to $10,000 a month | Sites with budget and no BD person | Stopping the retainer stops the conversations |
| Site networks and SMOs | $3,000 to $8,000 a month | Sites in an indication the network sells well | Revenue share and exclusivity clauses |
| Trial intelligence platforms | Five figures a year | Teams that will work the data daily | It is a database, the outreach is still yours |
| Apollo | Free to about $99 per user a month | Sites wanting a simple all-in-one | Tells you who exists, with no protocol timing |
| Instantly | $37 to $97 a month | The sending layer of a larger system | It sends, and that is all it does |
| ZoomInfo | Five figures a year | Networks with a dedicated sales team | The price makes no sense for one site |
1. Lead Gen Library system (ours)
This site publishes a documented n8n system for clinical research sites: workflows that read the public trial registry daily, find sponsors whose site list is still open, and run a five-step sequence from your own domain.
Disclosure: we build and sell this system, so read the rest of the list as the alternatives we compare ourselves against.
| Tier | Price |
|---|---|
| Full spec | Free PDF |
| Importable workflow files | $297 |
| Done-for-you install | $2,997 |
| Running cost | The tool stack, about $181 a month, plus your time |
- Strength. It reaches a sponsor while the site list is still open, on a record the sponsor published itself.
- Weakness. It does not fit a site whose calendar comes entirely from one CRO master agreement, because the seat it writes to has no say there.
2. A clinical business development agency
Agencies and fractional BD consultants charge $3,000 to $10,000 a month to work sponsor and CRO relationships on a site’s behalf.
- Strength. The good ones arrive with real contacts at feasibility groups and know how a site selection visit is graded.
- Weakness. The relationships belong to the consultant, so stopping the retainer usually stops the conversations.
Agencies fit sites with budget that cannot hire a full-time BD manager yet.
3. Site networks and SMOs
Networks and site management organizations pool member sites and sell them to sponsors as one coverage offer, typically $3,000 to $8,000 a month.
- Strength. A network strong in your therapeutic area can fill a calendar without you contacting anyone.
- Weakness. Revenue share is normal and member agreements often restrict what you may pursue on your own.
- What decides it. Whether that network is strong in your indications or somebody else’s.
Networks fit sites willing to trade margin and independence for volume.
4. Trial intelligence platforms
Citeline and Clarivate sell trial and sponsor intelligence built on the same public registry plus their own analyst layer, generally five figures a year.
- Strength. Good coverage, clean company records, and analyst context the raw registry does not carry.
- Weakness. It is a database. Nothing in the subscription writes an email, finds the feasibility seat, or follows a study whose completion date slips.
These platforms fit teams large enough to have somebody working the data every day.
5. Apollo
Apollo is a contact database with built-in email sequencing, from free to about $99 per user a month. For a site it covers finding clinical operations titles and emailing them, in one tool.
- Strength. One tool for the contact data and the send.
- Weakness: timing. Apollo tells you a clinical operations director exists, and it cannot tell you which sponsor registered a study last week with too few sites named.
Apollo fits sites that want a simple all-in-one and will live with generic targeting.
6. Instantly
Instantly is a cold email sending tool, around $37 to $97 a month, with strong deliverability tooling and unlimited sending accounts on higher plans.
- Strength. It sends well, and that is all it does.
- Weakness. You still need a source of studies, a seat to write to, and reply handling.
Instantly fits as the sending layer inside a larger system, and this is exactly the role it plays in our own stack.
7. ZoomInfo
ZoomInfo is the enterprise contact database, typically five figures a year.
- Strength. Data quality on mid-size and large sponsors is the best available, and intent signals are included on higher tiers.
- Weakness. For a single site or a small network the price makes no sense against a free registry that carries the actual timing.
It starts fitting at network scale with a dedicated sales team.
How to choose
Match the option to your real constraint:
- You want the channel and will run software. A self-run system gives the lowest cost per feasibility conversation and you keep the record history.
- Budget, no BD person. An agency or a network is the honest choice, priced accordingly.
- You already have a BD team. A trial intelligence subscription makes their day faster and still leaves the outreach to build.
The free clinical research site spec documents our version of the self-run option in full, so you can judge that path with the actual architecture in front of you before spending anything.
